PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) shot up 0.1% during trading on Friday . The company traded as high as $1.63 and last traded at $1.61. 2,032 shares were traded during mid-day trading, a decline of 77% from the average session volume of 8,831 shares. The stock had previously closed at $1.61.
PharmaCyte Biotech Stock Performance
The company’s 50 day moving average is $1.64 and its 200 day moving average is $1.75.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Read More
- Five stocks we like better than PharmaCyte Biotech
- How to Short a Stock in 5 Easy Steps
- Nebius Group: Market Overreaction or Real AI Disruption?
- What Do S&P 500 Stocks Tell Investors About the Market?
- The Best Way to Invest in Gold Is…
- What is a Death Cross in Stocks?
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
